We read the research article entitled Is cardiac resyn- chronisation therapy feasible, safe and beneficial in the very elderly? with great interest. The authors emphasized that despite the average age of heart failur...We read the research article entitled Is cardiac resyn- chronisation therapy feasible, safe and beneficial in the very elderly? with great interest. The authors emphasized that despite the average age of heart failure was 77 years in the general population of UK,patients receiving cardiac re- synchronisation therapy [with pacemaker alone (CRT-P) or with additional defibrillator capabilities (CRT-D)] were on younger ages at 72 and 67 years respectively. In the lights of this data, we agree with the authors that CRT seems to be undemtilized in the elderly patients with heart failure.展开更多
文摘We read the research article entitled Is cardiac resyn- chronisation therapy feasible, safe and beneficial in the very elderly? with great interest. The authors emphasized that despite the average age of heart failure was 77 years in the general population of UK,patients receiving cardiac re- synchronisation therapy [with pacemaker alone (CRT-P) or with additional defibrillator capabilities (CRT-D)] were on younger ages at 72 and 67 years respectively. In the lights of this data, we agree with the authors that CRT seems to be undemtilized in the elderly patients with heart failure.